Concepedia

Dina Shlyakhter

DS

Statistics

Publications

4

Citations

311

H-Index

4

Active since

1997

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Dina Shlyakhter is an author at Vertex Pharmaceuticals (United States) specializing in pharmacology, immunology, and medicine.

Publications per year

1997–2015

4

Publications

4

Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP

Ursula A. Germann, Pamella J. Ford, Dina Shlyakhter et al. · Anti-Cancer Drugs · 1997 · 132 citations

Medicine, Oncology, Pharmacology +15

Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes

Jugnu Jain, Susan J. Almquist, Pamella J. Ford et al. · Biochemical Pharmacology · 2003 · 86 citations

Life Sciences, Cell Biology, Immunology +6

VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease

Sudipta Mahajan, James K. Hogan, Dina Shlyakhter et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 60 citations

Medicine, Immunology, Pharmacology +16

Characterization of Pharmacological Efficacy of VX-148, a New, Potent Immunosuppressive Inosine 5′-Monophosphate Dehydrogenase Inhibitor

Jugnu Jain, Susan J. Almquist, Angela D. Heiser et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 33 citations

Medicine, Immunology, Pharmacology +17

1–4 of 4